Veloxis Pharmaceuticals
Doug Daniels has extensive experience in quality control and analytical development spanning over 30 years. Doug has held roles such as Sr. Director of Quality Control at Veloxis Pharmaceuticals, Director of Analytical Development at Ironshore Pharmaceuticals, Manager and Sr. Scientist at GSK, and Scientist II Group Leader at Magellan Laboratories. Doug'sexpertise includes overseeing analytical method development, validation, and transfer for various drug substances and products, providing scientific and technical leadership, managing teams, and budgeting for analytical activities. Additionally, they have experience as a Product Specialist at Fisons Instruments and as a Research and Development Chemist at LabCorp, specializing in forensic toxicology and GC/MS analysis.
Doug Daniels holds a Bachelor of Science degree in Chemistry from Purdue University. In addition, they obtained a Lean Six Sigma Green Belt certification from Durham Technical Community College in 2010 and an Achievers certification from the Bell Leadership Institute in 2022.
This person is not in any offices
Veloxis Pharmaceuticals
Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, develops improved versions of difficult-to-formulate drugs with its proprietary drug formulation technology, called MeltDose®.